Evotec SE, DE0005664809

Evotec stock heads into the open after closing at EUR 2.80

Published on 09/24/2026 at 06:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Evotec stock ended at EUR 2.80 on Xetra after trading between EUR 2.78 and EUR 2.83. The company is scheduled to present at BioProcess International US East 2026 today.

Fotorealistisches Pharma-Labor mit Wissenschaftlern bei Wirkstoffscreening in moderner Biotech-Anlage
Fotorealistisches Pharma-Labor symbolisiert Wirkstoffforschung von Evotec SE, ISIN DE0005664809, moderner Biotech-Standort Hamburg, Illustration mit AI erstellt.

Evotec stock closed at EUR 2.80 on Xetra on September 23, 2026, down 0.1 percent in the session. The shares traded between EUR 2.78 and EUR 2.83, while the MDAX stood at 31,310 points during the afternoon.

September 23, 2026 in numbers

Evotec SE (ISIN DE0005664809, Xetra: EVT) opened at EUR 2.79 and reached a session high of EUR 2.83 before finishing at EUR 2.80 on September 23, 2026. Trading volume had reached 485,706 shares by 4:28 p.m. local time, according to Finanzen.ch. The close was EUR 0.07, or 2.5 percent, above the 52-week low of EUR 2.73 and EUR 4.50 below the 52-week high of EUR 7.30.

The stock was among the MDAX decliners during the afternoon, when the index was quoted at 31,310 points. A dated market report also identified a company presentation at BioProcess International US East 2026 in Boston on September 23 and September 24, 2026.

BioProcess presentation continues today

Evotec is scheduled to present at BioProcess International US East 2026 on September 24, 2026, according to AD HOC NEWS. The event is the main company-specific item scheduled for the session.

Disclaimer...

en | DE0005664809 | EVOTEC SE | boerse | 70173604 | bgmi